NYSE - Delayed Quote USD
Enzo Biochem, Inc. (ENZ)
As of 10:05 AM EST. Market Open.
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-26,259.0000
-26,259.0000
-36,976.0000
-16,590.0000
387.0000
Investing Cash Flow
-545.0000
-545.0000
98,980.0000
25,223.0000
-34,497.0000
Financing Cash Flow
-4,193.0000
-4,193.0000
-1,125.0000
-241.0000
-242.0000
End Cash Position
52,371.0000
52,371.0000
83,373.0000
22,603.0000
14,274.0000
Capital Expenditure
-545.0000
-545.0000
-2,760.0000
-3,472.0000
-4,436.0000
Issuance of Capital Stock
--
--
386.0000
--
--
Issuance of Debt
--
--
23,846.0000
--
--
Repayment of Debt
-3,719.0000
-3,719.0000
-24,982.0000
-269.0000
-339.0000
Free Cash Flow
-26,804.0000
-26,804.0000
-39,736.0000
-20,062.0000
-4,049.0000
7/31/2021 - 6/12/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ERFSF Eurofins Scientific SE
48.80
0.00%
8VP1.F Avricore Health Inc.
0.0350
+1.45%
PRPH ProPhase Labs, Inc.
0.7599
+1.32%
ACRS Aclaris Therapeutics, Inc.
2.3609
+15.17%
IDXG Interpace Biosciences, Inc.
2.8500
0.00%
XGN Exagen Inc.
3.0453
+2.20%
OCX OncoCyte Corporation
2.6700
+2.30%
ICBU iMD Companies, Inc.
0.0060
+13.21%
NEOG Neogen Corporation
15.25
+4.45%
AVCR.V Avricore Health Inc.
0.0650
+8.33%